Ontogeny of atrial natriuretic peptide and its receptor in the lung: effects on perinatal surfactant release

Pediatr Res. 2008 Mar;63(3):239-44. doi: 10.1203/PDR.0b013e318163a215.

Abstract

During the transition at birth to air breathing, regulation of surfactant release from alveolar type II (ATII) cells is critical. Atrial natriuretic peptide (ANP) stimulates natriuretic peptide receptor-A (NPR-A) and increases intracellular cGMP. We examined the changes in ANP and NPR-A in respiratory epithelium during the perinatal period using immunohistochemistry and studied the effect of ANP on surfactant release from ATII cells isolated from fetal and newborn lambs. NPR-A mRNA was detected in the fetal lung by Northern Blot and RT-PCR. At 100 d gestation (term 145 d), ANP staining was absent and NPR-A staining was weak in cuboidal epithelial cells. ANP and NPR-A staining was prominent in ATII cells at 136 d gestation and was undetectable postnatally. ANP stimulated (maximal effect at 10(-10)M) surfactant release from both late gestation fetal and neonatal ATII cells. Protein kinase G inhibition significantly blocked this release. We conclude that ANP stimulates surfactant release in isolated perinatal ATII cells by a cGMP-dependent mechanism. ANP and NPR-A expression in ATII cells is greatest in late gestation and declines sharply postnatally. We speculate that increased activity of the ANP/NPR-A pathway in late gestation may prime the surfactant system, preparing the lung for air breathing.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Atrial Natriuretic Factor / metabolism*
  • Blotting, Northern
  • Cells, Cultured
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Cyclic GMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic GMP-Dependent Protein Kinases / metabolism
  • Gestational Age
  • Guanylate Cyclase / genetics
  • Guanylate Cyclase / metabolism*
  • Immunohistochemistry
  • Lung / drug effects
  • Lung / embryology
  • Lung / enzymology
  • Lung / growth & development
  • Lung / metabolism*
  • Phosphatidylcholines / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Pulmonary Surfactants / metabolism*
  • RNA, Messenger / metabolism
  • Receptors, Atrial Natriuretic Factor / genetics
  • Receptors, Atrial Natriuretic Factor / metabolism*
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / embryology
  • Respiratory Mucosa / enzymology
  • Respiratory Mucosa / growth & development
  • Respiratory Mucosa / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sheep
  • Signal Transduction* / drug effects
  • Thionucleotides / pharmacology
  • Time Factors

Substances

  • Phosphatidylcholines
  • Protein Kinase Inhibitors
  • Pulmonary Surfactants
  • RNA, Messenger
  • Thionucleotides
  • 8-bromo-beta-phenyl-1,N(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate
  • Atrial Natriuretic Factor
  • Cyclic GMP-Dependent Protein Kinases
  • Guanylate Cyclase
  • Receptors, Atrial Natriuretic Factor
  • atrial natriuretic factor receptor A
  • Cyclic GMP